Lonza India plans to double its turnover by 2024
Express Pharma|January 16-31, 2020
Lonza is a global integrated solutions provider for pharma, consumer healthcare, and nutrition segments. Deepak Sood, MD, Lonza India talks about the company's plans for the Indian market, its strategic focus areas, and more in an exclusive interview with Express Pharma
Lonza India plans to double its turnover by 2024

How large and important is Lonza's focus on the Indian market? What are your revenue and growth targets for India's pharma business?

Lonza India is a wholly-owned subsidiary of Switzerland-based and world's leading, integrated solutions provider for pharma and consumer healthcare. Lonza started its operations in India in 1997 as a liaison office. The office was involved mainly into sourcing advanced intermediates from India. Lonza came in as a fullfledged sales and commercial organisation with the acquisition of Cambrex Bio Products in 2007 and was renamed as Lonza India in 2008.

As India is a strategic market for the company, Lonza India has set the target of doubling its turnover by 2024 with an estimated growth of over 14 per cent. Therefore, Lonza India, recently opened its Corporate Office in Gurugram (Delhi-NCR). The new office was inaugurated by Andreas Baum, Ambassador of Switzerland to India who emphasized on India and Switzerland’s full-fledged partnership with each side benefiting from the strength of the other.

Tell us about Lonza India’s product offerings and strategic focus?

The offerings consist of products for cell discovery, molecular biology, rapid testing tools, fine chemical intermediates and pharma and intermediates for agrochemicals, consumer health and nutrition, biocides for industrial application, disinfectants for hospitals and various performance chemicals. Lonza India is now focusing on achieving the strategic vision of being a leading, integrated solutions provider for its pharma, consumer healthcare and nutrition customers all along the healthcare continuum in India.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM EXPRESS PHARMAView all
MAKING SUSTAINABILITY SUSTAINABLE
Express Pharma

MAKING SUSTAINABILITY SUSTAINABLE

Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, MSME pharma companies need to carefully balance their sustainability goals with financial viability

time-read
10+ mins  |
September 2024
New energy recovery system for tablet coaters
Express Pharma

New energy recovery system for tablet coaters

Upto 50 per cent less steam energy consumption

time-read
5 mins  |
September 2024
The future of pharma logistics: Trends, challenges, and opportunities
Express Pharma

The future of pharma logistics: Trends, challenges, and opportunities

Nikhil Agarwal, President, CJ Darcl Logistics explains that the future of pharma logistics is a thrilling frontier shaped by technological advancements, regulatory challenges, and the imperative of sustainability. As the industry transforms, logistics providers must embrace innovative solutions and adapt to shifting demands

time-read
3 mins  |
September 2024
Achieving Aatmanirbharta In APIs Are We On The Right Track?
Express Pharma

Achieving Aatmanirbharta In APIs Are We On The Right Track?

As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats

time-read
9 mins  |
August 2021
Yokogawa launches OpreX Data Model Broker
Express Pharma

Yokogawa launches OpreX Data Model Broker

A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation

time-read
2 mins  |
August 2021
Understanding the nuances of generics injectables
Express Pharma

Understanding the nuances of generics injectables

At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial

time-read
6 mins  |
August 2021
Trending in nutraceuticals: Science meets sustainability
Express Pharma

Trending in nutraceuticals: Science meets sustainability

Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe

time-read
3 mins  |
August 2021
The growth of e-pharmacies in India
Express Pharma

The growth of e-pharmacies in India

Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these

time-read
4 mins  |
August 2021
Xylitol and Maltitol: Low-calorie sugar alternatives
Express Pharma

Xylitol and Maltitol: Low-calorie sugar alternatives

Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste

time-read
4 mins  |
August 2021
Single-use TC gaskets and their importance
Express Pharma

Single-use TC gaskets and their importance

Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.

time-read
2 mins  |
August 2021